Dashboard
Manage Tickers

ASRT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

assertio-presents-data-on-sympazan-showing-how-it-is-being-used-in-daily-clinical-practice-to-treat-patients-with-lennox-gastaut-syndrome
Assertio Presents Data On SYMPAZAN Showing...
09/15/2025 13:04:10

New data show how Sympazan is being used in daily clinical practice to treat patients with Lennox-Gastaut Syndrome (LGS), a sev...

assertio-holdings-will-present-new-data-for-sympazan-clobazam-at-the-annual-meeting-of-the-american-neurological-association
Assertio Holdings Will Present New Data Fo...
09/10/2025 11:32:20

Poster presentation will feature new data for SYMPAZAN, the only FDA-approved oral film formulation of clobazam for adjunctive ...

reuters-reports-fda-saying-assertio-specialty-pharmaceuticals-discontinues-manufacturing-of-otrexup-injection
Reuters Reports FDA Saying Assertio Specia...
08/29/2025 13:58:45

hc-wainwright--co-maintains-buy-on-assertio-holdings-lowers-price-target-to-3
HC Wainwright & Co. Maintains Buy on Asser...
08/12/2025 12:08:31

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Assertio Holdings (NASDAQ:ASRT) with a Buy and lowers the price...

assertio-holdings-narrows-fy2025-sales-guidance-from-10800m-12300m-to-10800m-11800m-vs-11372m-est
Assertio Holdings Narrows FY2025 Sales Gui...
08/11/2025 20:08:05

Assertio Holdings (NASDAQ:ASRT) narrows FY2025 sales outlook from $108.00 million-$123.00 million to $108.00 million-$118.00 mi...

assertio-holdings-q2-adj-eps-002-beats-008-estimate-sales-2922m-beat-2786m-estimate
Assertio Holdings Q2 Adj. EPS $0.02 Beats ...
08/11/2025 20:07:07

Assertio Holdings (NASDAQ:ASRT) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

assertio-holdings-earnings-preview
Assertio Holdings Earnings Preview
08/08/2025 20:08:08

hc-wainwright--co-reiterates-buy-on-assertio-holdings-maintains-35-price-target
HC Wainwright & Co. Reiterates Buy on Asse...
05/19/2025 11:30:36

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Assertio Holdings (NASDAQ:ASRT) with a Buy and maintains $3.5 ...

assertio-holdings-q1-adj-eps-004-beats-006-estimate-sales-2649m-miss-2752m-estimate
Assertio Holdings Q1 Adj. EPS $(0.04) Beat...
05/12/2025 20:03:28

Assertio Holdings (NASDAQ:ASRT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0...

Core News & Articles
Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

a-look-at-assertio-holdingss-upcoming-earnings-report
A Look at Assertio Holdings's Upcoming Ear...
05/09/2025 20:04:41

hc-wainwright--co-maintains-buy-on-assertio-holdings-lowers-price-target-to-35
HC Wainwright & Co. Maintains Buy on Asser...
03/19/2025 10:50:11

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Assertio Holdings (NASDAQ:ASRT) with a Buy and lowers the price...

assertio-holdings-sees-fy25-sales-108m-123m-vs-123686m-est
Assertio Holdings Sees FY25 Sales $108M-$1...
03/12/2025 20:18:49

assertio-holdings-q4-2024-adj-eps-003-beats-004-estimate-sales-32182m-beat-28674m-estimate
Assertio Holdings Q4 2024 Adj. EPS $(0.03)...
03/12/2025 20:17:16

Assertio Holdings (NASDAQ:ASRT) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0...

earnings-scheduled-for-march-12-2025
Earnings Scheduled For March 12, 2025
03/12/2025 08:32:26

hc-wainwright--co-reiterates-buy-on-assertio-holdings-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Asse...
12/16/2024 12:11:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Assertio Holdings (NASDAQ:ASRT) with a Buy and maintains $4 pr...

assertio-announces-results-of-a-clinical-trial-investigating-the-utility-of-rolvedon-injection-when-dosed-the-same-day-of-chemotherapy-for-patients-with-early-stage-breast-cancer
Assertio Announces Results Of A Clinical T...
12/13/2024 13:03:42

Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a pharmaceutical company with comprehensiv...

hc-wainwright--co-reiterates-buy-on-assertio-holdings-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Asse...
11/25/2024 13:01:12

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Assertio Holdings (NASDAQ:ASRT) with a Buy and maintains $4 pr...

assertio-holdings-q3-2024-adj-eps-003-beats-005-estimate-sales-29204m-beat-28869m-estimate
Assertio Holdings Q3 2024 Adj. EPS $0.03 B...
11/11/2024 21:04:45

Assertio Holdings (NASDAQ:ASRT) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION